https://medicaex.com/prnewswire/bdt-capital-partners-acquires-minority-stake-in-exyte/ 2022-11-16T14:12:33+00:00 https://medicaex.com/wp-content/uploads/2022/11/Exyte_Logo-lC5NFG.jpeg https://medicaex.com/prnewswire/genesis-medtech-unveils-new-revolutionary-medtech-campus/ 2022-11-16T13:12:40+00:00 https://medicaex.com/wp-content/uploads/2022/11/Genesis_MedTech_Campus-8R5aQP.jpeg https://medicaex.com/prnewswire/sentinel-diagnostics-launches-sentinat-200-the-fully-automated-sample-to-result-system-for-the-diagnosis-of-viral-infections/ 2022-11-16T13:12:40+00:00 https://medicaex.com/wp-content/uploads/2022/11/Sentinel_Diagnostics_Logo-tVHXJH.jpeg https://medicaex.com/prnewswire/simcere-and-idorsia-enter-into-a-licensing-agreement-for-daridorexant-in-china/ 2022-11-16T13:12:31+00:00 https://medicaex.com/prnewswire/tianlong-showcases-innovative-smart-pcr-lab-solution-at-medica-2022/ 2022-11-16T13:12:31+00:00 https://medicaex.com/wp-content/uploads/2022/11/image_1-GutFKv.jpeg https://medicaex.com/prnewswire/telix-acquires-optimal-tracers/ 2022-11-16T12:12:38+00:00 https://medicaex.com/wp-content/uploads/2022/11/Telix_Main_Logo_Logo-lC6YlA.jpeg https://medicaex.com/prnewswire/antengene-highlights-encouraging-atg-008-efficacy-results-from-torch-2-study-in-combination-with-pd-1-antibody-in-relapsed-metastatic-cervical-cancer/ 2022-11-16T03:12:22+00:00 https://medicaex.com/wp-content/uploads/2022/11/ANTENGENE_EN_Logo-be5zks.jpeg https://medicaex.com/prnewswire/world-health-summit-kicks-off-with-german-chancellor-scholz-numerous-government-officials-who-director-general-tedros/ 2022-11-16T02:12:20+00:00 https://medicaex.com/prnewswire/ascletis-announces-ind-approval-of-viral-polymerase-inhibitor-asc10-for-monkeypox-indication-by-u-s-fda/ 2022-11-16T01:12:27+00:00 https://medicaex.com/prnewswire/nona-biosciences-announces-attendance-at-pegs-europe-2022/ 2022-11-16T00:12:30+00:00 https://medicaex.com/wp-content/uploads/2022/11/image_5002497_14525360-aInWtz.jpeg https://medicaex.com/prnewswire/striving-together-upgrading-the-biopharma-industry-international-biopharma-industry-week-shanghai-2022-kicks-off/ 2022-11-16T00:12:30+00:00 https://medicaex.com/wp-content/uploads/2022/11/photo-KqS7rv.jpeg https://medicaex.com/prnewswire/island-to-present-at-world-antiviral-congress-2022/ 2022-11-16T00:12:18+00:00 https://medicaex.com/prnewswire/daewoong-pharmaceutical-surpasses-krw-300-billion-in-q3-revenue-as-nabota-sales-grew-by-93-leading-overall-growth-in-revenue/ 2022-11-16T00:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/graph_on_Daewoong_Pharmaceutical_2022_3Q_financial_result-HwOT2d.jpeg https://medicaex.com/prnewswire/chinese-nmpa-approves-pivotal-phase-iii-study-of-tlx591-cdx-for-prostate-cancer-imaging/ 2022-11-15T23:12:30+00:00 https://medicaex.com/wp-content/uploads/2022/11/Telix_Main_Logo_Logo-HcCRxk.jpeg https://medicaex.com/prnewswire/green-goo-announces-nfl-linebacker-shaq-thompson-as-brand-ambassador/ 2022-11-15T16:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/Green_Goo_NFL-MuzTUJ.jpeg https://medicaex.com/prnewswire/alphyn-biologics-completes-first-cohort-of-phase2a-clinical-trial-of-topical-therapeutic-for-mild-to-moderate-atopic-dermatitis/ 2022-11-15T15:12:45+00:00 https://medicaex.com/wp-content/uploads/2022/11/Alphyn_Biologics__LLC__Logo_Hi_Res_Transparent_Bckgrd_Logo-vIx48F.jpeg https://medicaex.com/prnewswire/hanall-biopharma-reports-third-quarter-2022-results-and-provides-business-update/ 2022-11-15T15:12:20+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Up30Df.jpeg https://medicaex.com/prnewswire/harbour-biomed-launches-nona-biosciences-ideas-to-ind-preclinical-solutions-business-to-accelerate-global-biotherapeutic-innovation/ 2022-11-15T13:22:28+00:00 https://medicaex.com/wp-content/uploads/2022/11/Nona-mft4ac.jpeg https://medicaex.com/prnewswire/biotheus-has-entered-into-a-license-and-collaboration-agreement-with-hansoh-pharma-for-its-egfr-met-bispecific-antibody-in-the-greater-china-territory/ 2022-11-15T11:17:34+00:00 https://medicaex.com/prnewswire/everest-medicines-announces-new-drug-application-acceptance-by-china-nmpa-for-nefecon-for-the-treatment-of-primary-iga-nephropathy/ 2022-11-15T11:17:34+00:00 https://medicaex.com/prnewswire/innovent-announces-first-participant-dosed-in-a-phase-3-clinical-study-glory-1-of-mazdutide-ibi362-in-chinese-adults-with-overweight-or-obesity/ 2022-11-15T11:17:34+00:00 https://medicaex.com/prnewswire/chocolate-touch-next-generation-drug-coated-angioplasty-balloon-for-the-treatment-of-peripheral-arterial-disease-receives-fda-approval/ 2022-11-15T10:12:41+00:00 https://medicaex.com/prnewswire/mindray-ultrasound-launches-multicenter-research-for-sea-regions/ 2022-11-15T10:12:35+00:00 https://medicaex.com/wp-content/uploads/2022/11/1-XdnPNM.jpeg https://medicaex.com/prnewswire/yili-wins-the-2022-global-water-drinks-award/ 2022-11-15T09:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/1-ts6cNx.jpeg https://medicaex.com/prnewswire/more-than-four-in-ten-consumers-globally-think-eating-plant-based-food-will-replace-meat-in-the-next-decade/ 2022-11-15T09:12:16+00:00 https://medicaex.com/prnewswire/the-worlds-first-eta-specific-monoclonal-antibody-gmax-biopharms-gma131-approved-by-the-us-fda-for-clinical-study-on-dkd-diabetic-kidney-disease/ 2022-11-15T07:12:27+00:00 https://medicaex.com/wp-content/uploads/2022/11/image_5013070_29784398-zxKEwH.jpeg https://medicaex.com/prnewswire/antengene-presents-promising-results-from-four-preclinical-studies-at-the-2022-society-for-immunotherapy-of-cancer-annual-meeting/ 2022-11-15T04:12:41+00:00 https://medicaex.com/wp-content/uploads/2022/11/ANTENGENE_EN_Logo-eJghEN.jpeg https://medicaex.com/prnewswire/with-new-commitment-gates-foundation-joins-call-to-help-end-polio/ 2022-11-15T04:12:23+00:00 https://medicaex.com/prnewswire/ventureblick-launches-global-search-for-healthcare-startups-most-endorsed-by-the-medical-community-2/ 2022-11-15T02:12:19+00:00 https://medicaex.com/wp-content/uploads/2022/11/VentureBlick_launches_global_search_healthcare_startups__most_endorsed_medical_community-UH3Hpu.jpeg https://medicaex.com/prnewswire/ventureblick-launches-global-search-for-healthcare-startups-most-endorsed-by-the-medical-community/ 2022-11-15T02:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/VentureBlick_launches_global_search_healthcare_startups__most_endorsed_medical_community-gXQ4sn.jpeg https://medicaex.com/prnewswire/first-global-state-of-digital-health-report-tapping-into-200-million-data-points-examining-over-12000-digital-health-ventures-released-at-hlth/ 2022-11-14T16:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/State_of_Digital_Health_Report-pH2UZe.jpeg https://medicaex.com/prnewswire/shiang-ding-targets-us-market-with-healthy-herbal-beverage-alternatives/ 2022-11-14T16:12:16+00:00 https://medicaex.com/prnewswire/ascentage-pharma-announces-ind-approval-in-china-for-phase-i-study-of-apg-5918-in-patients-with-advanced-solid-tumors-or-hematologic-malignancies/ 2022-11-14T15:12:46+00:00 https://medicaex.com/wp-content/uploads/2022/11/Ascentage_Pharma_Logo-KUDbv4.jpeg https://medicaex.com/prnewswire/kintor-pharma-announces-oral-presentation-at-ash-2022-highlighting-the-data-from-novel-dual-c-myc-gspt1-degrader-gt19715/ 2022-11-14T15:12:46+00:00 https://medicaex.com/prnewswire/alma-academy-was-successfully-held-in-dubai-with-the-global-launch-of-alma-duo-2/ 2022-11-14T15:12:39+00:00 https://medicaex.com/prnewswire/alma-academy-was-successfully-held-in-dubai-with-the-global-launch-of-alma-duo/ 2022-11-14T15:12:39+00:00 https://medicaex.com/prnewswire/medical-device-connectivity-market-growth-helps-overcome-healthcare-professionals-challenges/ 2022-11-14T14:12:45+00:00 https://medicaex.com/wp-content/uploads/2022/11/GettyImages_1250152635-jxvIeg.jpeg https://medicaex.com/prnewswire/innovent-presents-clinical-data-of-phase-ia-study-for-ibi351-kras-g12c-inhibitor-as-monotherapy-for-solid-tumors-at-the-2022-chinese-society-of-clinical-oncology-csco-annual-meeting/ 2022-11-14T14:12:37+00:00 https://medicaex.com/prnewswire/global-innovation-challenge-2023-inviting-participants-in-living-assistance-robot-contest-designed-to-help-people-with-disabilities-walk-independently/ 2022-11-14T13:12:44+00:00 https://medicaex.com/prnewswire/monash-university-implements-antibody-discovery-application-by-utilizing-the-berkeley-lights-beacon-platform/ 2022-11-14T09:12:37+00:00 https://medicaex.com/wp-content/uploads/2022/11/Berkeley_Lights_Logo-1jbKny.jpeg https://medicaex.com/prnewswire/lotus-reports-its-best-quarter-ever-with-the-biggest-launch-in-its-history/ 2022-11-14T09:12:29+00:00 https://medicaex.com/wp-content/uploads/2022/11/Lotus_new_building-iUgBS1.jpeg https://medicaex.com/prnewswire/taurx-announces-additional-investment-of-usd119-million-following-announcement-of-phase-3-lucidity-topline-results/ 2022-11-14T08:12:37+00:00 https://medicaex.com/prnewswire/amorepacific-publishes-its-findings-on-dietary-restrictions-and-lifespan-extension-in-nature-communications/ 2022-11-14T07:12:43+00:00 https://medicaex.com/wp-content/uploads/2022/11/Amorepacific_discovered_the_effects_of_the_essential_amino_acid__threonine__on_promoting_both_life_a-DsEppo.jpeg https://medicaex.com/prnewswire/mednovation-entered-into-strategic-cooperation-with-lsi/ 2022-11-14T06:12:24+00:00 https://medicaex.com/prnewswire/alterity-therapeutics-announces-presentation-of-data-from-the-biomuse-natural-history-study-at-the-american-autonomic-society-annual-meeting/ 2022-11-14T01:12:38+00:00 https://medicaex.com/wp-content/uploads/2022/11/Alterity_Logo-QTeH9W.jpeg https://medicaex.com/prnewswire/alpinion-medical-systems-showcasing-the-latest-intelligent-ultrasound-technology-at-rsna-2022/ 2022-11-14T01:12:34+00:00 https://medicaex.com/wp-content/uploads/2022/11/XC_lineup_name-Rgzk0H.jpeg https://medicaex.com/prnewswire/industry-innovation-ai-smile-smart-tracking-case-debut-worldwide-developed-by-weiyun-ai-robotics-group/ 2022-11-14T01:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/PR-vbq8pW.jpeg https://medicaex.com/prnewswire/bridgewest-group-inks-deal-with-pfizer-to-acquire-injectable-manufacturing-plant-in-western-australia/ 2022-11-14T00:12:23+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bridgewest_Acquires_Perth_stock_photo-8b7RSO.jpeg https://medicaex.com/prnewswire/harbour-biomed-enters-into-a-license-and-collaboration-agreement-with-moderna/ 2022-11-14T00:12:23+00:00 https://medicaex.com/wp-content/uploads/2022/11/HB_for_email_Logo-pTeQNS.jpeg https://medicaex.com/prnewswire/new-report-finds-over-90-of-australian-women-suffer-from-period-related-symptoms/ 2022-11-13T23:12:26+00:00 https://medicaex.com/prnewswire/toosonix-announces-granted-patents-for-its-non-invasive-treatments-of-dermatological-conditions/ 2022-11-13T22:12:31+00:00 https://medicaex.com/prnewswire/health-canada-approves-illuccix-for-prostate-cancer-imaging/ 2022-11-13T00:12:29+00:00 https://medicaex.com/wp-content/uploads/2022/11/Telix_Main_Logo_Logo-lAsOb1.jpeg https://medicaex.com/prnewswire/research-collaboration-between-prof-antonio-gasbarrini-team-at-gemelli-hospital-and-asian-biotech-companies-coree-and-dxvx/ 2022-11-12T12:12:37+00:00 https://medicaex.com/wp-content/uploads/2022/11/1__Mater_Ecclesiae__Rome_Centre-6nu8gw.jpeg https://medicaex.com/prnewswire/telix-to-present-at-jefferies-london-healthcare-conference-2022/ 2022-11-11T13:12:31+00:00 https://medicaex.com/wp-content/uploads/2022/11/Telix_Main_Logo_Logo-psZ9hk.jpeg https://medicaex.com/prnewswire/transcenta-presented-two-scientific-posters-at-sitc-2022-annual-meeting/ 2022-11-11T12:12:36+00:00 https://medicaex.com/prnewswire/so-young-to-report-third-quarter-2022-financial-results-on-november-18-2022/ 2022-11-11T11:13:22+00:00 https://medicaex.com/prnewswire/seekin-demonstrates-the-power-of-treatment-response-monitoring-test-at-the-association-for-molecular-pathology-amp-2022-annual-meeting-expo/ 2022-11-11T09:12:42+00:00 https://medicaex.com/prnewswire/frost-sullivan-institute-recognizes-exemplary-companies-winning-the-enlightened-growth-leadership-awards-for-the-second-time/ 2022-11-11T08:13:58+00:00 https://medicaex.com/wp-content/uploads/2022/11/Frost_Sullivan_Institute-t3lYfg.jpeg https://medicaex.com/prnewswire/smithnephew-academy-singapore-opens-bringing-medical-education-and-digital-innovation-to-healthcare-professionals-across-asia-pacific/ 2022-11-11T07:12:40+00:00 https://medicaex.com/wp-content/uploads/2022/11/Smith_Nephew_Logo-L7snn2.jpeg https://medicaex.com/prnewswire/ys-biopharma-announces-us-fda-clearance-of-ind-application-for-pika-covid-19-vaccine/ 2022-11-11T07:12:31+00:00 https://medicaex.com/wp-content/uploads/2022/11/YS_Biopharma_Logo-FQjvqH.jpeg https://medicaex.com/prnewswire/preliminary-results-from-two-clinical-studies-of-selinexor-to-be-presented-at-2022-ash-annual-meeting/ 2022-11-11T06:12:42+00:00 https://medicaex.com/wp-content/uploads/2022/11/ANTENGENE_EN_Logo-OprFSU.jpeg https://medicaex.com/prnewswire/ascom-applauded-by-frost-sullivan-for-improving-hospital-medical-device-workflows-with-its-mdi-platform/ 2022-11-11T06:12:38+00:00 https://medicaex.com/wp-content/uploads/2022/11/Ascom_Award-RHKTNy.jpeg https://medicaex.com/prnewswire/prenetics-announces-record-third-quarter-2022-financial-results-and-raises-full-year-2022-revenue-and-ebitda-guidance/ 2022-11-11T06:12:27+00:00 https://medicaex.com/prnewswire/the-new-thread-lift-with-approved-design-patent-timemachine-lift-thread-anchoring-dual-cog/ 2022-11-11T05:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/TIMEMACHINE_LIFT_IMG-Bw1zLT.jpeg https://medicaex.com/prnewswire/oncoshot-and-novotech-partner-to-offer-cancer-data-insights/ 2022-11-11T03:12:27+00:00 https://medicaex.com/wp-content/uploads/2022/11/Novotech_X_Oncoshot-dGlXIZ.jpeg https://medicaex.com/prnewswire/hexvix-a-diagnostic-drug-for-bladder-cancer-of-asieris-completed-the-first-patient-dose-in-phase-iii-trial/ 2022-11-11T02:12:42+00:00 https://medicaex.com/prnewswire/cbc-backed-abio-x-appoints-pharmaceutical-and-healthcare-veteran-dr-jeffrey-jonas-as-ceo/ 2022-11-11T02:12:28+00:00 https://medicaex.com/prnewswire/asieris-obtained-ind-approval-from-us-fda-for-apl-1401-a-new-drug-for-the-treatment-of-moderately-to-severely-active-ulcerative-colitis/ 2022-11-11T02:12:28+00:00 https://medicaex.com/prnewswire/telix-announces-positive-topline-results-of-zircon-phase-iii-kidney-cancer-imaging-study/ 2022-11-11T00:12:39+00:00 https://medicaex.com/wp-content/uploads/2022/11/Telix_Main_Logo_Logo-HVnzwF.jpeg https://medicaex.com/prnewswire/cordis-promotes-alan-tsai-as-gm-greater-china/ 2022-11-10T16:12:37+00:00 https://medicaex.com/prnewswire/china-marches-into-the-era-of-interventional-direct-annuloplasty/ 2022-11-10T15:12:44+00:00 https://medicaex.com/wp-content/uploads/2022/11/Valgen_Medtech-QY2eVf.jpeg https://medicaex.com/prnewswire/itri-introduces-point-of-care-ai-dr-software-for-rapid-diagnosis-of-diabetic-retinopathy-and-diabetic-macular-edema/ 2022-11-10T15:12:21+00:00 https://medicaex.com/wp-content/uploads/2022/11/Point_of_Care_AI_DR_Photo-ukdswt.jpeg https://medicaex.com/prnewswire/medison-pharma-announces-expansion-of-the-multi-territorial-agreement-with-immunocore-into-latin-america/ 2022-11-10T14:12:34+00:00 https://medicaex.com/wp-content/uploads/2022/11/MEDISON_Logo-ilIkR8.jpeg https://medicaex.com/prnewswire/mentice-receives-grant-from-swedens-innovation-agency-to-improve-synthetic-image-generation/ 2022-11-10T13:12:32+00:00 https://medicaex.com/prnewswire/transcenta-to-hold-3-exchange-sessions-on-post-sitc-business-update-call-tst003-data-release-and-pipeline-development-progress-update/ 2022-11-10T11:12:29+00:00 https://medicaex.com/prnewswire/iaso-biotherapeutics-and-cabaletta-bio-announce-exclusive-worldwide-license-agreement-for-clinically-validated-cd19-binder/ 2022-11-10T10:12:31+00:00 https://medicaex.com/wp-content/uploads/2022/11/image_1-u32JG0.jpeg https://medicaex.com/prnewswire/keenon-robotics-signed-strategic-partnership-with-sgp-marked-official-entry-into-senior-living-and-healthcare-industries-in-canada/ 2022-11-10T10:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/KEENON_ROBOTICS_X_SGP_COOPERATION-O9t6Cl.jpeg https://medicaex.com/prnewswire/nsw-health-cicada-innovations-celebrate-australias-biggest-health-startup-training-program-with-1-1k-participants-in-first-year/ 2022-11-10T08:12:33+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cicada_Innovations_CEO_Sally_ann_Williams-CeqcM2.jpeg https://medicaex.com/prnewswire/strong-business-performance-in-9m-2022-exyte-increases-order-intake-sales-and-profitability/ 2022-11-10T08:12:27+00:00 https://medicaex.com/wp-content/uploads/2022/11/Exyte_Logo-l0kc1B.jpeg https://medicaex.com/prnewswire/global-innovation-challenge-2023-inviting-participants-in-living-assistance-robot-contest-designed-to-help-people-with-disabilities-walk-independently-2/ 2022-11-10T08:12:18+00:00 https://medicaex.com/prnewswire/werfen-to-acquire-immucor-inc-expanding-its-presence-in-specialized-diagnostics/ 2022-11-10T06:13:34+00:00 https://medicaex.com/wp-content/uploads/2022/11/Werfen_President_Marc_Rubiralta-QVwsZj.jpeg https://medicaex.com/prnewswire/axiomtek-launches-the-newest-medical-grade-artificial-intelligence-computing-system-mbox100/ 2022-11-10T06:13:19+00:00 https://medicaex.com/wp-content/uploads/2022/11/image_5019367_31655331-YRrodF.jpeg https://medicaex.com/prnewswire/docquity-digitized-patient-affordability-programs-in-the-philippines-saving-over-us1m-for-patients/ 2022-11-10T03:12:36+00:00 https://medicaex.com/wp-content/uploads/2022/11/Docquity_PAP_Infographic_1-LNbzcU.jpeg https://medicaex.com/prnewswire/certa-therapeutics-investigational-drug-ft011-delivers-breakthrough-results-as-a-potential-novel-treatment-for-serious-inflammatory-and-fibrotic-diseases/ 2022-11-10T01:12:40+00:00 https://medicaex.com/prnewswire/siemens-healthineers-to-demonstrate-the-remote-capabilities-of-corindus-corpath-grx-robotic-system-using-mentice-vist-simulator/ 2022-11-10T01:12:28+00:00 https://medicaex.com/prnewswire/first-sea-genomic-data-digitisation-collaboration-formed-to-improve-cancer-clinical-trial-access/ 2022-11-09T23:12:40+00:00 https://medicaex.com/wp-content/uploads/2022/11/IMG_9550-hBQXIj.jpeg https://medicaex.com/prnewswire/angus-acquires-expression-systems-llc/ 2022-11-09T21:12:22+00:00 https://medicaex.com/wp-content/uploads/2022/11/ANGUS_Chemical_Company_Logo-Fq1UMw.jpeg https://medicaex.com/prnewswire/shanghai-operation-robot-announced-the-first-robot-assisted-human-clinical-trial-of-biliary-stent-placement-surgery/ 2022-11-09T20:12:32+00:00 https://medicaex.com/wp-content/uploads/2022/11/image_5019479_10694527-gRxiTX.jpeg https://medicaex.com/prnewswire/tes-pharma-congratulates-intercept-pharmaceuticals-on-their-presentation-of-phase-1-int-787-data-at-the-aasld-meeting-and-the-initiation-of-the-phase-2a-fresh-study-in-patients-with-severe-alcohol-ass/ 2022-11-09T20:12:23+00:00 https://medicaex.com/prnewswire/himalaya-therapeutics-announces-highlights-of-recent-clinical-progress/ 2022-11-09T15:12:33+00:00 https://medicaex.com/wp-content/uploads/2022/11/himalaya_therapeutics_Logo-QYJVkO.jpeg https://medicaex.com/prnewswire/wat-medical-entrusted-by-geely-auto-to-develop-neuromodulation-technologies-to-improve-travel-experiences/ 2022-11-09T13:12:41+00:00 https://medicaex.com/wp-content/uploads/2022/11/Geely_Auto_Entrusts_WAT_Medical_To_Develop_Neuromodulation_Technologies_To-mJQgKE.jpeg https://medicaex.com/prnewswire/nicomatic-announces-global-distribution-partnership-with-pei-genesis/ 2022-11-09T11:12:22+00:00 https://medicaex.com/wp-content/uploads/2022/11/Nicomatic_Logo-vC6xLo.jpeg https://medicaex.com/prnewswire/jw-therapeutics-announces-its-cell-immunotherapy-drugs-have-successfully-benefited-300-patients/ 2022-11-09T10:12:26+00:00 https://medicaex.com/wp-content/uploads/2022/11/300pt_EN______KV_20221107-k0KhrV.jpeg https://medicaex.com/prnewswire/omega-healthcare-named-a-leader-in-medical-coding-operations-peak-matrix-assessment-2023/ 2022-11-09T09:13:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/MCOPEAK2023_ID_dd4a9750ab9e-khDtVj.jpeg https://medicaex.com/prnewswire/orthalign-inc-adds-balance-feature-to-their-lantern-platform-including-indications-for-primary-and-revision-knee-arthroplasty/ 2022-11-09T04:12:33+00:00 https://medicaex.com/prnewswire/eit-healths-venture-centre-of-excellence-names-productlife-group-as-privileged-partner-for-regulatory-compliance/ 2022-11-09T04:12:25+00:00 https://medicaex.com/prnewswire/ground-breaking-sirius-endoscope-system-is-leading-the-next-minimally-invasive-surgical-revolution/ 2022-11-08T22:12:32+00:00 https://medicaex.com/wp-content/uploads/2022/11/Precision_Robotics_SIRIUS_Robotic_Flexible_Endoscope_System_Photo_1-28n34N.jpeg https://medicaex.com/prnewswire/announcement-of-the-effect-of-ginseng-and-red-ginseng-for-suppression-of-bone-and-muscle-loss-announced-at-the-13th-international-symposium-on-ginseng-2022/ 2022-11-08T17:12:43+00:00 https://medicaex.com/wp-content/uploads/2022/11/Professor_Narayanan-HQuc55.jpeg https://medicaex.com/prnewswire/lumc-to-fund-new-clinical-trial-of-cynatas-cymerus-mscs-in-kidney-transplantation/ 2022-11-08T16:12:55+00:00 https://medicaex.com/prnewswire/scolicare-opens-its-first-clinic-in-the-us/ 2022-11-08T16:12:25+00:00 https://medicaex.com/wp-content/uploads/2022/11/ScoliBrace_by_ScoliCare-tV4Hsn.jpeg https://medicaex.com/prnewswire/biorchestra-announces-that-bmd-001-reduces-amyloid-%ce%b2-and-tau-in-non-human-primate-animal-model-of-alzheimers-disease-at-the-rna-leaders-usa-conference-in-boston/ 2022-11-08T15:12:32+00:00 https://medicaex.com/wp-content/uploads/2022/11/image_5018367_28176461-wsNzIJ.jpeg https://medicaex.com/prnewswire/insilico-medicine-signs-strategic-research-collaboration-with-sanofi-worth-up-to-1-2-billion/ 2022-11-08T15:12:31+00:00 https://medicaex.com/prnewswire/akeso-completes-enrollment-in-phase-iii-trial-of-pd-1-vegf-bispecific-antibody-ak112-combined-with-chemotherapy-in-egfr-tki-resistant-nsq-nsclc/ 2022-11-08T14:12:53+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_Logo-PBVORZ.jpeg https://medicaex.com/prnewswire/update-on-overseas-clinical-trials-progress-of-novel-adjuvant-covid-19-vaccine-recov/ 2022-11-08T14:12:36+00:00 https://medicaex.com/wp-content/uploads/2022/11/Recbio_Logo-RbifXI.jpeg https://medicaex.com/prnewswire/111-to-announce-third-quarter-2022-unaudited-financial-results-on-december-1-2022-conference-call-to-follow/ 2022-11-08T14:12:36+00:00 https://medicaex.com/prnewswire/xjtlu-and-university-of-liverpool-to-inaugurate-joint-centre-for-pharmacology-and-therapeutics/ 2022-11-08T14:12:33+00:00 https://medicaex.com/wp-content/uploads/2022/11/1667894493034-k5PhC8.jpeg https://medicaex.com/prnewswire/real-world-application-of-lunit-insight-to-be-spotlighted-at-rsna-2022-oral-presentations/ 2022-11-08T13:12:48+00:00 https://medicaex.com/wp-content/uploads/2022/11/Lunit_INSIGHT_CXR_Lunit_INSIGHT_MMG-CKgMe5.jpeg https://medicaex.com/prnewswire/1-in-2-diabetics-suffer-from-peripheral-neuropathy1-during-their-lifetime/ 2022-11-08T13:12:37+00:00 https://medicaex.com/wp-content/uploads/2022/11/image_1-bw0WBB.jpeg https://medicaex.com/prnewswire/sirnaomics-doses-the-first-patient-in-phase-i-clinical-trial-of-rnai-therapeutic-stp705-in-adults-undergoing-abdominoplasty-for-medical-aesthetics-treatment/ 2022-11-08T13:12:37+00:00 https://medicaex.com/prnewswire/novavax-prototype-covid-19-vaccine-data-support-homologous-and-heterologous-boosting-and-suggest-benefit-against-variants/ 2022-11-08T13:12:31+00:00 https://medicaex.com/wp-content/uploads/2022/11/Novavax_High_Res_Logo-tkM9mO.jpeg https://medicaex.com/prnewswire/zepp-health-corporation-to-report-third-quarter-2022-financial-results-on-november-21-2022/ 2022-11-08T13:12:26+00:00 https://medicaex.com/prnewswire/national-institute-of-korean-medicine-shows-a-new-trend-in-korean-medicine-in-times-square-new-york/ 2022-11-08T12:12:34+00:00 https://medicaex.com/wp-content/uploads/2022/11/1-Mb0Q5j.jpeg https://medicaex.com/prnewswire/ainos-reports-unaudited-third-quarter-2022-financial-results/ 2022-11-08T07:12:28+00:00 https://medicaex.com/prnewswire/pulnovo-medical-inhales-tens-of-millions-dollars-funding-to-accelerate-global-growth/ 2022-11-08T06:12:25+00:00 https://medicaex.com/prnewswire/world-one-health-congress-commences-in-singapore/ 2022-11-08T05:12:17+00:00 https://medicaex.com/prnewswire/docdoc-to-work-with-aon-and-insurers-in-asia-to-offer-data-enabled-patient-empowerment-solutions-to-members-of-employer-health-plans/ 2022-11-08T02:12:16+00:00 https://medicaex.com/prnewswire/cyagen-and-neurophth-enter-global-strategic-collaboration-to-develop-ai-designed-aav-gene-therapy-vectors-for-ophthalmic-disorders/ 2022-11-08T01:12:26+00:00 https://medicaex.com/wp-content/uploads/2022/11/image-oSYDV2.jpeg https://medicaex.com/prnewswire/ash-2022-ascentage-pharma-to-present-initial-data-of-bcl-2-inhibitor-lisaftoclax-apg-2575-in-combination-with-btk-inhibitors-for-the-treatment-of-r-r-cll-sll-including-an-orr-of-98-in-an-oral-re/ 2022-11-07T15:12:41+00:00 https://medicaex.com/wp-content/uploads/2022/11/Ascentage_Pharma_Logo-RQTpz0.jpeg https://medicaex.com/prnewswire/hummingbird-bioscience-announces-two-hmbd-002-poster-presentations-at-the-society-for-immunotherapy-of-cancer-2022-annual-meeting/ 2022-11-07T14:12:31+00:00 https://medicaex.com/prnewswire/ash-2022-ascentage-pharma-to-present-data-of-olverembatinib-hqp1351-in-three-oral-reports-including-the-first-dataset-from-the-first-us-study-at-the-ash-annual-meeting/ 2022-11-07T13:12:43+00:00 https://medicaex.com/wp-content/uploads/2022/11/Ascentage_Pharma_Logo-VrjFzo.jpeg https://medicaex.com/prnewswire/gracell-biotechnologies-to-present-first-clinical-data-of-fastcar-t-gc012f-for-newly-diagnosed-multiple-myeloma-at-64th-american-society-of-hematology-annual-meeting-exposition/ 2022-11-07T13:12:43+00:00 https://medicaex.com/wp-content/uploads/2022/11/gracell_logo_Logo-TQEB2S.jpeg https://medicaex.com/prnewswire/innovent-releases-results-of-a-phase-3-clinical-study-of-tafolecimab%ef%bc%88ibi306%ef%bc%89in-chinese-patients-with-non-familial-hypercholesterolemia-at-the-american-heart-association-aha-scirntif/ 2022-11-07T13:12:29+00:00 https://medicaex.com/prnewswire/brexogens-exosome-therapy-for-atopic-dermatitis-bre-ad01-accepted-for-phase-1-clinical-trials-by-us-fda/ 2022-11-07T13:12:29+00:00 https://medicaex.com/wp-content/uploads/2022/11/Brexogen_Logo-aDb2dB.jpeg https://medicaex.com/prnewswire/hma-partners-baxter-to-deliver-webinar-series-on-patient-care-challenges-and-innovations/ 2022-11-07T11:12:24+00:00 https://medicaex.com/prnewswire/spark-clear-aligners-release-13-provides-highly-anticipated-orthodontic-innovations-with-ground-breaking-and-exclusive-clinical-features/ 2022-11-07T10:12:32+00:00 https://medicaex.com/wp-content/uploads/2022/11/Spark_Clear_Aligners_Logo-rx2tje.jpeg https://medicaex.com/prnewswire/roche-introduces-the-navify-brand-for-its-digital-health-solutions-at-hlth-2022/ 2022-11-07T10:12:21+00:00 https://medicaex.com/wp-content/uploads/2022/11/navify_Graphic-SYeeas.jpeg https://medicaex.com/prnewswire/five-new-drug-candidates-show-promise-as-ainos-pursues-licensing-partners-of-its-low-dose-oral-interferon-formulation/ 2022-11-07T06:12:32+00:00 https://medicaex.com/prnewswire/ema-aesthetics-signs-agreement-with-4ocean-to-become-plastics-neutral/ 2022-11-07T04:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/EMA_Logo-iZ1Hzr.jpeg https://medicaex.com/prnewswire/eccogene-announces-us-ind-approval-for-glp-1-receptor-agonist-ecc5004/ 2022-11-07T02:12:33+00:00 https://medicaex.com/wp-content/uploads/2022/11/Eccogene__logo_Logo-tKvAdF.jpeg https://medicaex.com/prnewswire/ascletis-announces-poster-presentation-of-phase-i-single-dose-study-of-asc43f-for-nash-at-aasld-annual-meeting-2022/ 2022-11-07T01:12:21+00:00 https://medicaex.com/wp-content/uploads/2022/11/2-7320JK.jpeg https://medicaex.com/prnewswire/first-in-human-use-of-oncores-medicals-cancer-imaging-system-successful/ 2022-11-06T22:12:41+00:00 https://medicaex.com/prnewswire/kira-pharmaceuticals-presents-complete-data-from-phase-1-synergy-1-trial-of-kp104-at-american-society-for-nephrology-kidney-week-2022/ 2022-11-06T22:12:26+00:00 https://medicaex.com/wp-content/uploads/2022/11/Kira_Pharma_China_Logo-WIcQkP.jpeg https://medicaex.com/prnewswire/zeiss-makes-fifth-appearance-at-ciie-placing-great-effort-in-localization-strategy/ 2022-11-06T07:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/ZEISS_China_Maximillan_Foerst-AUKaOw.jpeg https://medicaex.com/prnewswire/daewoong-pharmaceutical-presents-phase-3-clinical-trial-results-of-new-diabetes-treatment-enavogliflozin-and-roadmap-to-enter-50-countries-by-2030/ 2022-11-05T17:12:38+00:00 https://medicaex.com/wp-content/uploads/2022/11/Daewoong_Pharmaceuticals_Logo-DpHeQg.jpeg https://medicaex.com/prnewswire/immuno-cure-appoints-new-cfo/ 2022-11-05T17:12:32+00:00 https://medicaex.com/prnewswire/turtletree-to-represent-singapore-at-un-climate-change-conference-2022-as-official-drink-partner/ 2022-11-04T19:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Zenith_PR_Key_Visual_1920_x_1080-TY5mRJ.jpeg https://medicaex.com/prnewswire/waterdrop-launches-insurance-against-breast-cancer-recurrence/ 2022-11-04T15:12:17+00:00 https://medicaex.com/prnewswire/waterdrop-wins-the-nbd-annual-insurtech-progress-award/ 2022-11-04T14:12:18+00:00 https://medicaex.com/prnewswire/new-randomized-controlled-study-published-in-jama-demonstrates-the-value-of-clinical-decision-support-tools-in-preventing-acute-kidney-injury-in-patients-undergoing-coronary-angiography/ 2022-11-04T12:12:43+00:00 https://medicaex.com/wp-content/uploads/2022/11/Terumo_Logo-DVvCtO.jpeg https://medicaex.com/prnewswire/i-mab-announces-two-poster-presentations-of-cd47-antibody-lemzoparlimab-at-ash-2022/ 2022-11-04T12:12:30+00:00 https://medicaex.com/wp-content/uploads/2022/11/I_MAB_Logo-HeQaSH.jpeg https://medicaex.com/prnewswire/yuyu-pharma-attendance-at-european-pharmaceutical-conference/ 2022-11-04T06:13:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Yuyu_Pharma_attendance_at_European_Pharmaceutical_Conference-4I0Qsj.jpeg https://medicaex.com/prnewswire/zhongchao-inc-s-china-operating-entity-chongqing-xinjiang-pharmaceutical-co-ltd-obtained-pharmaceutical-trade-and-medical-device-operation-licenses-ready-to-enter-into-pharmaceuticals-circulati/ 2022-11-04T03:12:26+00:00 https://medicaex.com/prnewswire/genscript-supported-nasal-spray-development-for-covid-19-protection-with-gmp-grade-antibodies-and-subsequently-planned-for-long-term-collaboration-with-biogenexis/ 2022-11-04T01:12:40+00:00 https://medicaex.com/wp-content/uploads/2022/11/image_1-AdyfgC.jpeg https://medicaex.com/prnewswire/announcement-of-the-effect-of-ginseng-and-red-ginseng-for-memory-improvement-and-suppression-of-bone-and-muscle-loss/ 2022-11-04T00:12:40+00:00 https://medicaex.com/wp-content/uploads/2022/11/Korean_Society_of_Ginseng_image-U2nr6V.jpeg https://medicaex.com/prnewswire/merck-kgaa-darmstadt-germany-and-p-chip-corporation-collaborate-to-improve-trust-and-transparency-in-machine-to-machine-driven-industrial-value-chains/ 2022-11-04T00:12:26+00:00 https://medicaex.com/prnewswire/akeso-announces-oral-presentation-of-ivonescimab-pd-1-vegf-bi-specific-in-first-line-treatment-of-es-sclc-on-aclc-2022/ 2022-11-03T19:12:36+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_Logo-6ZfrsB.jpeg https://medicaex.com/prnewswire/senhwa-announces-first-patient-successfully-dosed-in-phase-i-study-of-pindnarulex-in-combination-with-pfizers-talazoparib-for-the-treatment-of-prostate-cancer/ 2022-11-03T19:12:36+00:00 https://medicaex.com/wp-content/uploads/2022/11/Senhwa_Logo_Logo_Logo-3Hued6.jpeg https://medicaex.com/prnewswire/accuray-announces-tomo-c-registration-submission-to-chinas-national-medical-products-administration/ 2022-11-03T19:12:32+00:00 https://medicaex.com/wp-content/uploads/2022/11/accuray_incorporated_logo-PAWicd.jpeg https://medicaex.com/prnewswire/cctv-lyrics-of-white-peony-root-into-the-air/ 2022-11-03T19:12:23+00:00 https://medicaex.com/prnewswire/hinova-disclosed-the-preclinical-results-of-hp518-oral-ar-protac-at-the-5th-annual-tpd-summit-2/ 2022-11-03T13:12:38+00:00 https://medicaex.com/prnewswire/turn-biotechnologies-names-25-year-biotech-industry-veteran-richard-peterson-chief-financial-officer/ 2022-11-03T13:12:25+00:00 https://medicaex.com/wp-content/uploads/2022/11/Turn_Biotechnologies_Ric_Peterson-M9WD0S.jpeg https://medicaex.com/prnewswire/nuevocor-to-present-pre-clinical-data-on-its-gene-therapy-candidate-for-lmna-dilated-cardiomyopathy-at-american-heart-association-scientific-sessions-2022/ 2022-11-03T11:12:41+00:00 https://medicaex.com/prnewswire/dr-amit-kakar-joins-medgenome-board-of-directors/ 2022-11-03T11:12:29+00:00 https://medicaex.com/prnewswire/simcere-receives-fda-clearance-of-investigational-new-drug-application-ind-for-bi-functional-fusion-protein-sim0237/ 2022-11-03T05:12:35+00:00 https://medicaex.com/prnewswire/gerresheimer-ag-and-stevanato-group-present-ez-fill-smart-a-new-and-innovative-ready-to-fill-vial-platform/ 2022-11-03T03:12:30+00:00 https://medicaex.com/prnewswire/kintor-pharma-announces-completion-of-subject-enrollment-and-dosing-in-phase-i-clinical-trial-of-ar-protacgt20029-in-the-us/ 2022-11-02T22:12:39+00:00 https://medicaex.com/prnewswire/antengene-announces-ind-approval-for-the-phase-i-stamina-001-study-to-evaluate-atg-037-cd73-inhibitor-for-the-treatment-of-locally-advanced-or-metastatic-solid-tumors-in-china/ 2022-11-02T13:12:23+00:00 https://medicaex.com/wp-content/uploads/2022/11/ANTENGENE_EN_Logo-AWxUGh.jpeg https://medicaex.com/prnewswire/inteleos-to-convene-global-health-leaders-to-develop-community-specific-ultrasound-programs-aimed-at-lowering-maternal-and-fetal-mortality-rates-in-kenya/ 2022-11-02T12:12:23+00:00 https://medicaex.com/prnewswire/everise-named-to-inc-s-inaugural-power-partner-awards/ 2022-11-02T08:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Everise_named_Power_Partner_2022-Sn5x3B.jpeg https://medicaex.com/prnewswire/codex-genetics-to-offer-guardant-healths-precision-oncology-tests-in-hong-kong-and-macau/ 2022-11-02T05:12:29+00:00 https://medicaex.com/prnewswire/nccn-working-with-medlive-to-advance-high-quality-cancer-care-in-china-and-worldwide/ 2022-11-02T02:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/NCCN_Logo-WPZo0G.jpeg https://medicaex.com/prnewswire/ascletis-announces-u-s-ind-filing-of-oral-3clpro-inhibitor-asc11-for-covid-19/ 2022-11-02T01:12:17+00:00 https://medicaex.com/prnewswire/karyopharm-and-menarini-group-announce-orphan-medicinal-product-designation-from-the-european-commission-for-selinexor-for-the-treatment-of-myelofibrosis/ 2022-11-02T00:13:28+00:00 https://medicaex.com/wp-content/uploads/2022/11/MENARINI_Group_Logo-Kxzyjb.jpeg https://medicaex.com/prnewswire/cbc-healthcare-infrastructure-platform-acquires-prime-industrial-land-in-shanghai-to-develop-a-high-specifications-life-science-park/ 2022-11-01T17:12:35+00:00 https://medicaex.com/prnewswire/i-peace-partners-with-the-california-institute-for-regenerative-medicine-cirm/ 2022-11-01T17:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/I_Peace_Inc_Logo_Logo-4K0Im0.jpeg https://medicaex.com/prnewswire/broncuss-disposable-nebulizing-micro-catheter-for-endoscope-was-approved-for-marketing-in-china-and-its-applications-in-drug-device-combination-will-be-broadened/ 2022-11-01T14:12:35+00:00 https://medicaex.com/prnewswire/world-stroke-organization-tackle-gaps-in-access-to-quality-stroke-care/ 2022-11-01T14:12:35+00:00 https://medicaex.com/wp-content/uploads/2022/11/World_Stroke_Day_Campaign_1-UsYciw.jpeg https://medicaex.com/prnewswire/pervistop-the-once-daily-supplement-specifically-designed-to-manage-persistent-hpv-is-now-available-for-exclusive-distribution-rights-worldwide/ 2022-11-01T14:12:28+00:00 https://medicaex.com/wp-content/uploads/2022/11/Pervistop-lreMRa.jpeg https://medicaex.com/prnewswire/henlius-novel-anti-pd-1-mab-hansizhuang-serplulimab-receives-nmpa-approval-for-the-treatment-of-sqnsclc/ 2022-11-01T14:12:26+00:00 https://medicaex.com/prnewswire/havas-health-you-appoints-paul-kinsella-chief-creative-officer-of-hhy-europe/ 2022-11-01T14:12:19+00:00 https://medicaex.com/wp-content/uploads/2022/11/HH_Y_Logo_Logo-xFe5dP.jpeg https://medicaex.com/prnewswire/eyeguard-system-the-privacy-filter-specialist-launched-new-wellness-lifestyle-brand-anbac/ 2022-11-01T14:12:19+00:00 https://medicaex.com/wp-content/uploads/2022/11/1-RRi77Y.jpeg https://medicaex.com/prnewswire/gore-completes-first-in-human-implants-of-the-gore-viafort-vascular-stent/ 2022-11-01T13:12:38+00:00 https://medicaex.com/wp-content/uploads/2022/11/gore_logo_color_positive_rgb_Logo-aQRHem.jpeg https://medicaex.com/prnewswire/remegen-releases-phase-ii-clinical-study-data-for-treatment-of-myasthenia-gravis-in-chinese-patients/ 2022-11-01T13:12:28+00:00 https://medicaex.com/prnewswire/hummingbird-bioscience-to-attend-the-credit-suisse-31st-annual-healthcare-conference/ 2022-11-01T13:12:27+00:00 https://medicaex.com/prnewswire/metabolon-advances-the-understanding-of-inflammation-and-inflammatory-response-with-new-oxysterols-targeted-panel/ 2022-11-01T12:12:42+00:00 https://medicaex.com/wp-content/uploads/2022/11/Metabolon_Inc_Logo-GtyeCp.jpeg https://medicaex.com/prnewswire/hemotune-applauded-by-frost-sullivan-for-enabling-selective-and-efficient-extraction-of-large-compounds-from-blood-with-its-blood-purification-platform/ 2022-11-01T12:12:37+00:00 https://medicaex.com/wp-content/uploads/2022/11/hemotune_Award-vj1vBU.jpeg https://medicaex.com/prnewswire/dr-faika-khan-ceo-of-city-doctor-pvt-ltd-and-mr-ali-j-hashmat-ceo-of-cure-partners-pvt-ltd-announcement-of-full-acquisition-of-the-medical-laboratory-pvt-ltd-dba-zeenat-laboratories/ 2022-11-01T12:12:37+00:00 https://medicaex.com/prnewswire/carsgen-appoints-dr-sylvie-peltier-as-senior-vice-president-of-global-regulatory-affairs/ 2022-11-01T12:12:29+00:00 https://medicaex.com/wp-content/uploads/2022/11/Dr_Sylvie_Peltier-b4peMl.jpeg https://medicaex.com/prnewswire/cali-biosciences-announces-publications-of-phase-iia-results-of-long-acting-ropivacaine-cpl-01/ 2022-11-01T11:12:37+00:00 https://medicaex.com/prnewswire/icp-das-bmp-to-partake-in-the-compamed-2022-germany-for-the-first-time/ 2022-11-01T11:12:35+00:00 https://medicaex.com/wp-content/uploads/2022/11/Banner-BZJLlp.jpeg https://medicaex.com/prnewswire/gracell-biotechnologies-to-report-third-quarter-2022-financials-on-monday-november-14-2022/ 2022-11-01T11:12:28+00:00 https://medicaex.com/wp-content/uploads/2022/11/gracell_logo_Logo-vmc9xK.jpeg https://medicaex.com/prnewswire/antengene-receives-u-s-fda-clearance-of-ind-application-for-phase-i-trial-of-small-molecule-erk1-2-inhibitor-atg-017-in-patients-with-advanced-solid-tumors/ 2022-11-01T11:12:28+00:00 https://medicaex.com/wp-content/uploads/2022/11/ANTENGENE_EN_Logo-NOCDgL.jpeg https://medicaex.com/prnewswire/lunit-joins-world-economic-forum-global-innovators-community/ 2022-11-01T10:12:31+00:00 https://medicaex.com/wp-content/uploads/2022/11/Lunit_CI_Logo-EFSVik.jpeg https://medicaex.com/prnewswire/epivax-joins-intravacc-cepi-on-project-to-develop-universal-betacoronavirus-vaccine/ 2022-11-01T08:12:19+00:00 https://medicaex.com/wp-content/uploads/2022/11/EpiVax_Logo-veTEFb.jpeg https://medicaex.com/prnewswire/meet-the-female-scientists-who-develop-cellular-and-gene-therapies/ 2022-11-01T07:12:27+00:00 https://medicaex.com/wp-content/uploads/2022/11/20221026152934-VgSgT0.jpeg https://medicaex.com/prnewswire/xinhua-silk-road-cloud-offline-fair-injects-new-vitality-into-national-tcm-materials-pharmaceuticals-trade-fair/ 2022-11-01T04:12:22+00:00 https://medicaex.com/wp-content/uploads/2022/11/Xinhua_Silk_Road_Real_Time_Data-C3ktIL.jpeg https://medicaex.com/prnewswire/fda-accepts-nmps-clinical-trial-application-for-development-of-nmk89-as-imaging-agent-for-cancer-diagnosis/ 2022-11-01T03:12:34+00:00 https://medicaex.com/prnewswire/mentice-and-acandis-gmbh-announce-a-3-year-agreement-for-mentice-ankyras-clinical-support-software-solutions-at-a-value-of-8-9msek/ 2022-11-01T03:12:29+00:00 https://medicaex.com/prnewswire/mirxes-collaborates-with-plug-and-play-to-launch-southeast-asias-first-science-backed-commercialization-engine-and-validator-program/ 2022-11-01T03:12:29+00:00 https://medicaex.com/wp-content/uploads/2022/11/MiRXES-uRlzbW.jpeg https://medicaex.com/prnewswire/bowtie-partners-with-take2-and-scor-to-develop-an-innovative-cancer-screening-solution-sponsor-over-1000-high-risk-customers-to-conduct-early-nasopharyngeal-cancer-detection-test/ 2022-11-01T03:12:22+00:00 https://medicaex.com/prnewswire/free-webinar-medical-tourism-quick-wins-or-long-term-success/ 2022-10-31T20:12:15+00:00 https://medicaex.com/prnewswire/medalliance-selution-slr-receives-coronary-fda-ide-approval/ 2022-10-31T13:12:42+00:00 https://medicaex.com/wp-content/uploads/2022/10/MedAlliance_Image-cl36sd.jpeg https://medicaex.com/prnewswire/samyang-holdings-lafullen-makes-splash-in-korean-medical-aesthetics-market/ 2022-10-31T13:12:27+00:00 https://medicaex.com/prnewswire/genesiscare-and-preludedxtm-present-compelling-australian-first-dcisionrt-study-interim-analysis-during-breast-cancer-awareness-month-45-change-in-treatment-recommendations-when-using-dcisionrt/ 2022-10-31T13:12:27+00:00 https://medicaex.com/prnewswire/innovent-announces-first-patient-dosing-in-australia-in-phase-i-study-of-ibi343-recombinant-anti-claudin18-2-monoclonal-antibody-drug-conjugate-in-patients-with-advanced-solid-tumors/ 2022-10-31T13:12:27+00:00 https://medicaex.com/prnewswire/unload-psoriatic-disease-world-psoriasis-day-2022/ 2022-10-31T12:12:32+00:00 https://medicaex.com/wp-content/uploads/2022/10/Vicious_Cycle_World_Psoriasis_Day_2022-GZ4NJa.jpeg https://medicaex.com/prnewswire/t-cells-treated-by-turn-biotechnologies-show-increased-cancer-killing-effectiveness/ 2022-10-31T11:12:43+00:00 https://medicaex.com/wp-content/uploads/2022/10/GettyImages_1227506537-dT6foA.jpeg https://medicaex.com/prnewswire/g20-health-ministers-meeting-delivers-six-key-actions-for-the-upcoming-leaders-summit/ 2022-10-31T09:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/10/Image-0jbIk6.jpeg https://medicaex.com/prnewswire/liscure-biosciences-announces-oral-presentation-of-new-drug-candidate-for-nash-at-upcoming-aasld-the-liver-meeting-2022/ 2022-10-31T07:12:22+00:00 https://medicaex.com/prnewswire/infinitus-joins-hands-with-some-of-the-worlds-most-prestigious-universities-in-international-sci-tech-government-project/ 2022-10-31T02:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/10/image_985744_25931970-XHgL8D.jpeg